Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
HIV-1 protease inhibitors are very effective antiviral drugs. These drugs target HIV-1 proteases, which are required for viral replication.
Despite the success of protease inhibitors for suppressing HIV-1, some patients do not respond to protease inhibitor therapy. For most patients, the lack of response is not due to mutation of the HIV-1 protease.
In this issue of the Journal of Clinical Investigation, Robert Silcano and colleagues at Johns Hopkins University identify the effects of protease inhibitors on different stages of viral replication.
The authors found that protease inhibitors do not prevent virus release from infected cells, but do prevent viral entry into new cells, and have an effect on the reverse transcription and post-transcription stages of the HIV-1 life cycle. Additionally, mutations in the viral envelope protein, which is involved in cell entry, were associated with resistance to protease inhibitor treatment.
In the accompanying Attending Physician article, John Bartlett of Duke University discusses how these findings may dictate testing for HIV-1 envelope mutations in patients that have not responded to treatment with protease inhibitors.
TITLE: Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance J Clin Invest. doi:10.1172/JCI67399
ACCOMPANYING THE ATTENDING PHYSICIAN TITLE: Lack of protease inhibitor resistance following treatment failure - too good to be true? J Clin Invest. 2013;123(9):3704-3705. doi:10.1172/JCI71784.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our HIV / AIDS category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Multiple stages of the HIV-1 life cycle involved in protease inhibitor resistance." Medical News Today. MediLexicon, Intl., 29 Aug. 2013. Web.
5 Dec. 2013. <http://www.medicalnewstoday.com/releases/265315>
Journal of Clinical Investigation. (2013, August 29). "Multiple stages of the HIV-1 life cycle involved in protease inhibitor resistance." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265315.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.